Unknown

Dataset Information

0

SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.

ABSTRACT:

SUBMITTER: van der Werf I 

PROVIDER: S-EPMC8410582 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.
| S-EPMC7136967 | biostudies-literature
Unknown Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia.
| S-EPMC8440619 | biostudies-literature
Unknown Treatment of FLT3-ITD acute myeloid leukemia.
| S-EPMC3301423 | biostudies-literature
Unknown Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells.
| S-EPMC5493614 | biostudies-literature
Unknown T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.
| S-EPMC4741775 | biostudies-literature
Unknown Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia.
| S-EPMC3837509 | biostudies-literature
Unknown A novel prognostic scoring model for newly diagnosed FLT3-ITD-positive acute myeloid leukemia.
| S-EPMC7783775 | biostudies-literature
Unknown Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD-positive acute myeloid leukemia.
| S-EPMC9258203 | biostudies-literature
Unknown ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia.
| S-EPMC7212592 | biostudies-literature
Unknown Data-Driven Math Model of FLT3-ITD Acute Myeloid Leukemia Reveals Potential Therapeutic Targets.
| S-EPMC7998618 | biostudies-literature